Call for Papers

The Journal of Immunotherapy and Precision Oncology is seeking manuscripts about phase 1 trial design.

Topics for consideration include:

• How to set up a phase 1 unit
• New study designs in early clinical trials
• How to manage toxicities in phase 1 trials
• How to set up a molecular screening program

All manuscripts will be subjected to peer review in accordance with the Journal’s peer review policy. There is no guarantee of acceptance. Any questions should be directed to the editorial office: editor@innovationsjournals.com.